The export of medicines may be blocked if this leads to a shortage of medicines within the country.

On Saturday, Canada imposed restrictions on the mass export of prescription drugs if it causes a shortage of these drugs within the country. This measure was introduced in response to the decree of US President Donald Trump, who ordered to reduce the price of prescription drugs, including by importing them from neighboring Canada.

“Some medicines intended for the Canadian market are prohibited from being imported outside of Canada if this sale causes or exacerbates drug shortages,” said Health Minister Patty Hajdu.

“Now companies (importing medicines) will also be required to provide information to assess existing or potential shortages upon request (of the Ministry of Health) within 24 hours if there is a serious one… health risk to (Canadian consumers), ” the Health Minister said in a statement.

The order from the Canadian Health Minister came into effect on Friday, just days before new prescription drug import regulations are set to take effect in the US, which will allow us licensed companies to import prescription drugs made in Canada in bulk to the US.

Neither the White House nor the Department of Health and Human Services responded to a request for comment.

During his first debate with President-elect Joe Biden, Trump announced the plan, who also said during his campaign that he would develop a similar plan to import medical drugs to try to lower the cost of prescription drugs for Americans.

“Canada is a small market that accounts for 2% of global drug sales, with 68% of manufactured medicines delivered to the global market. Vigilance must be exercised in maintaining the national supply of medicines,” Health Canada said in a statement.

Many Canadian drug suppliers have opposed Trump’s plan, saying it could lead to a shortage of medicines.